accessibility menu, dialog, popup

UserName

CAS RN 103060-53-3

H3COHN(S)NHONH(S)NH2OOHN(S)OHOONHH3COO(S)ONH2NHO(S)HNO(R)OHNHOHNO(S)HOOHNO(R)CH3HNO(S)OHONHO(S)H2NHNONHOH3CHOO

CAS RN 103060-53-3

IUPAC Namn: (3S)-3-{[(3S,6S,9R,15S,18R,21S,24S)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]carbamoyl}-3-[(2S)-3-carbamoyl-2-[(2S)-2-decanamido-3-(1H-indol-3-yl)propanamido]propanamido]propanoic acid
Synonymer: daptomycin
Molekylvikt (g/mol): 1620.69
Molekylär sammansättning: C72H101N17O26
InChi Key: DOAKLVKFURWEDJ-OFNKPWESSA-N
SMILES: CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NC1C(C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)C(C)CC(O)=O
Molekylvikt (g/mol) 
  • (7)
  • (1)
Procent renhet 
  • (2)
  • (4)
  • (2)
Kvantitet 
  • (1)
  • (1)
  • (3)
  • (1)
  • (1)
  • (1)
Färg 
  • (1)
  • (2)
Kvalitet 
  • (1)
  • (2)

Filtrerade sökresultat

Produkter från vissa av våra leverantörer visas inte i filtrerade sökresultat. Vänligen Rensa alla filter för att se dessa produkter.

Begränsa resultat

Begränsa resultat

Kategori

Specialerbjudande

  • (2)

Varumärken

  • (2)
  • (1)
  • (2)
  • (2)
  • (3)

specialprogram

  • (3)
  • (2)

Molekylvikt (g/mol)

  • (7)
  • (1)

Procent renhet

  • (2)
  • (4)
  • (2)

Kvantitet

  • (1)
  • (1)
  • (3)
  • (1)
  • (1)
  • (1)

Färg

  • (1)
  • (2)

Kvalitet

  • (1)
  • (2)

Fysisk form

  • (1)
  • (2)

Produkttyp

  • (2)
1 – 5 av 5 Resultat
1
Kampanjer är tillgängliga

Thermo Scientific Chemicals Daptomycin

CAS: 103060-53-3 Molekylformel: C72H101N17O26 Molekylvikt (g/mol): 1620.67 InChI-nyckel: DOAKLVKFURWEDJ-AVSAZHKKSA-N Synonym: daptomycin PubChem CID: 133640189 LEDER: CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C

Molekylformel C72H101N17O26
PubChem CID 133640189
CAS 103060-53-3
InChI-nyckel DOAKLVKFURWEDJ-AVSAZHKKSA-N
LEDER CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C
Molekylvikt (g/mol) 1620.67
Synonym daptomycin
2

Daptomycin, TRC

CAS: 103060-53-3 Molekylformel: C72 H101 N17 O26 Molekylvikt (g/mol): 1620.67 Synonym: Daptomycin,1-Oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontane, cyclic peptide deriv.,Benzenebutanoic acid, N-(1-oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α,2-diamino-γ-oxo-, (13→4)-lactone, (αS)-,Cidecin,Cubicin,Dapcin,Daptomicina,Daptomycine,Daptomycinum,Deptomycin,LY 146032,N-(1-Oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-(αS)-α,2-diamino-γ-oxobenzenebutanoic acid (13→4)-lactone IUPAC-namn: (3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid LEDER: CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)c4ccccc4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@H](C)CC(=O)O

Molekylformel C72 H101 N17 O26
IUPAC-namn (3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid
CAS 103060-53-3
LEDER CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)c4ccccc4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@H](C)CC(=O)O
Molekylvikt (g/mol) 1620.67
Synonym Daptomycin,1-Oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontane, cyclic peptide deriv.,Benzenebutanoic acid, N-(1-oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α,2-diamino-γ-oxo-, (13→4)-lactone, (αS)-,Cidecin,Cubicin,Dapcin,Daptomicina,Daptomycine,Daptomycinum,Deptomycin,LY 146032,N-(1-Oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-(αS)-α,2-diamino-γ-oxobenzenebutanoic acid (13→4)-lactone
3

Tocris Bioscience™ Daptomycin
GREENER_CHOICE

CAS: 103060-53-3 Molekylformel: C72H101N17O26

Molekylformel C72H101N17O26
CAS 103060-53-3
4

Daptomycin, MedChemExpress

MedChemExpress Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.

ENCOMPASS_PREFERRED
Molekylformel C72H101N17O26
Rekommenderad förvaring Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month
Formel vikt 1620.67
Hållbarhet Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month
Löslighetsinformation H2O : 100 mg/mL (61.70 mM; Need ultrasonic) ∣DMSO : ≥ 100 mg/mL (61.70 mM)
Anteckningar om renhetsgrad Research
Fysisk form Powder
Kvalitet Research
Färg Off-White
CAS 103060-53-3
LEDER O=C(N[C@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@@](C(N[C@@H](C(N[C@H]1CC(O)=O)=O)C)=O)([H])CC(O)=O)=O)CCCN)=O)=O)[C@H](OC([C@](NC([C@](NC([C@@](NC(CNC1=O)=O)([H])CO)=O)([H])[C@H](C)CC(O)=O)=O)([H])CC(C(C=CC=C2)=C2N)=O)=O)C)=O)=O)[C@@H](NC(CCCCCCCCC)=O)CC3=CNC4=CC=CC=C34
Molekylvikt (g/mol) 1620.67
Synonym LY146032
Kemiskt namn eller material Daptomycin
Procent renhet 98.0%
För användning med (applikation) COVID-19-immunoregulation
5

TOKU-E™ Daptomycin ReadyMade™ Solution

Daptomycin ReadyMade™ Solution is provided as a sterile-filtered solution in ~ 10% β-cyclodextrin saline solution.

ENCOMPASS_PREFERRED